ClearCount Medical Solutions is a company.
Key people at ClearCount Medical Solutions.
ClearCount Medical Solutions was founded by Gautam Gandhi (Co-Founder).
ClearCount Medical Solutions was founded by Gautam Gandhi (Co-Founder).
ClearCount Medical Solutions is a medical device company that developed an RFID-based platform for patient safety, primarily the SmartSponge System, the only FDA-cleared solution for counting and detecting surgical sponges to prevent retained surgical items.[1][2][3] It served hospitals and operating rooms (O.R.s) by solving the critical problem of sponge-counting errors, which can lead to severe patient harm, while improving operational efficiency and reducing costs.[1][3] Founded in 2004 in Pittsburgh, Pennsylvania, the company raised $16.84M before being acquired by Stryker in 2014 for approximately $120M following resolved litigation.[1][2][3]
ClearCount Medical Solutions was founded in 2004 in Pittsburgh, Pennsylvania, focusing on innovative patient safety technologies for the medical device sector.[1][3] Specific founders are not detailed in available sources, but the company emerged to address a persistent O.R. challenge: ensuring accurate sponge counts during surgeries to avoid retained foreign objects.[1][2] Early traction included developing the SmartSponge System and SmartWand-DTX detection tool, culminating in a pivotal 2014 acquisition by Stryker after settling a patent infringement dispute with Patient Safety Technologies.[1][2] Pre-acquisition, it generated around $5.8M in annual revenue and received support from regional accelerators like Innovation Works.[3][4]
ClearCount stood out in the medical device space through these key strengths:
ClearCount rode the early-2010s wave of RFID and IoT adoption in healthcare, targeting preventable surgical errors—a major patient safety trend amplified by regulatory pressures like FDA guidelines on retained surgical items.[1] Timing was ideal amid rising focus on operational efficiency in hospitals facing cost constraints and malpractice risks, positioning RFID as a scalable, non-invasive fix over manual counts.[1][2] Market forces like growing medtech consolidation favored it, leading to Stryker's acquisition, which integrated the tech into a larger ecosystem influencing O.R. standards and inspiring similar detection tools from competitors like Cardinal Health.[1][5] This elevated patient safety innovations within medtech M&A trends.
Post-2014 acquisition, ClearCount's technologies are embedded in Stryker's portfolio, likely continuing evolution toward advanced surgical tracking amid trends like AI-enhanced detection and real-time O.R. analytics.[1][2] Rising demand for error-proofing in high-volume procedures, driven by aging populations and value-based care, will shape its legacy, potentially expanding to other RFID-tracked items. Its influence endures by setting a benchmark for FDA-cleared safety systems, tying back to its core mission of transforming routine O.R. tasks into reliable safeguards.[1][3]
Key people at ClearCount Medical Solutions.